NIH, vaccines

Dr. Jay Bhattacharya said he would seek ethical alternatives to using medical research based on cell lines taken from fetal tissue harvested from aborted babies decades ago.
Unlike President Trump's picks to lead other health agencies who established their conservative bona fides during the ...
Senators challenged Jay Bhattacharya, MD, PhD, President Donald Trump's pick to lead the National Institutes of Health (NIH), ...
Emergent BioSolutions is investing in Swiss biotech Rocketvax, inking a deal designed to fuel the preclinical company’s R&D. | Emergent BioSolutions is investing in Swiss biotech Rocketvax, inking a ...
Jay Bhattacharya said he’s “convinced” by the data showing there is no link between the measles, mumps, and rubella vaccine ...